How much V. how a drug is used
Nickerson, M.
Canadian Medical Association Journal 120(10): 1202
1979
ISSN/ISBN: 0008-4409 PMID: 445257 Document Number: 147883
Document emailed within 1 workday
Related Documents
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Merlin, Béatrice.; Chazard, E.; Pereira, S.; Serrot, E.; Sakji, S.; Beuscart, Régis.; Darmoni, S. 2010: Can F-MTI semantic-mined drug codes be used for adverse drug events detection when no CPOE is available? Studies in Health Technology and Informatics 160(Pt 2): 1025-1029
Yu, J.; Zheng, M.-s.; Xiao, C.-n.; Zheng, X.-h. 2015: Gray relational analysis for the effect of nano-drug features on drug absorption Yao Xue Xue Bao 50(9): 1096-1100
Horváth, Z. 1973: Studies on the causes for drug abuse using ethylmorphine hydrochloride and acetylsalicylic-acid-containing drug combinations Die Pharmazie 28(4): 242-243
Liu, C.T.; Adler, F.L. 1973: Immunologic studies on drug addiction. I. Antibodies reactive with methadone and their use for detection of the drug Journal of Immunology 111(2): 472-477
Vozeh, S. 1984: Drug level determination for optimization of drug therapy. Practical significance and new trends Schweizerische Rundschau für Medizin Praxis 73(49): 1505-1506
Jackevicius, C.A.; Tu, K.; Filate, W.A.; Brien, S.E.; Tu, J.V. 2003: Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001 Canadian Journal of Cardiology 19(12): 1359-1366
Bhatt, A.D. 1999: Drug-related problems and adverse drug events: negligence, litigation and prevention Journal of the Association of Physicians of India 47(7): 715-720
Senterre, J. 1999: Drug clinics. Drug of the month. A new measles-rubella-mumps vaccine (Priorix) Revue Medicale de Liege 54(2): 122-124
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686
Kamya, M.R.; Bakyaita, N.N.; Talisuna, A.O.; Were, W.M.; Staedke, S.G. 2002: Increasing antimalarial drug resistance in Uganda and revision of the national drug policy Tropical Medicine and International Health: Tm and Ih 7(12): 1031-1041
Taheri Zadeh, Z.; Rahmani, S.; Alidadi, F.; Joushi, S.; Esmaeilpour, K. 2021: Depresssion, anxiety and other cognitive consequences of social isolation: Drug and non-drug treatments International Journal of Clinical Practice 75(12): E14949
Bresnahan, K.; Zuckerman, B.; Cabral, H. 1992: Psychosocial correlates of drug and heavy alcohol use among pregnant women at risk for drug use Obstetrics and Gynecology 80(6): 976-980
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547